November 13, 2017
Nordic Nanovector to Present at Jefferies Global Healthcare Conference
Media
November 13, 2017
Q3 2017 General Market Overview
November 09, 2017
Wilson Therapeutics’ Nomination Committee appointed
November 09, 2017
Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update
November 08, 2017
CERENIS Therapeutics acquires LYPRO Biosciences expanding its HDL strategy into immuno-oncology and chemotherapeutic drug delivery
November 08, 2017
Nordic Nanovector: Protocol Amendment filed in the UK to enable initiation of Phase 2 PARADIGME
November 07, 2017
Nordic Nanovector ASA (OSE: NANO) to host Capital Markets Day and Present Q3 Results on 22 November 2017 in Oslo
November 07, 2017
Targovax ASA: Notice of Extraordinary General Meeting
November 07, 2017
Strongbridge Biopharma plc to Present at the Stifel 2017 Healthcare Conference
November 06, 2017
Strongbridge Biopharma plc to Host Third Quarter 2017 Financial Results Conference Call on November 14, 2017
